Racing forward: The genomics and personalized medicine act

Science

Volumn 323, Issue 5912, 2009, Pages 342-

  Lee, Sandra Soo Jin ^a   Mudaliar, Ashwin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE PLUS ISOSORBIDE DINITRATE;

DRUG DEVELOPMENT; GENOMICS; RESEARCH AND DEVELOPMENT;

CLINICAL RESEARCH; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC VARIABILITY; PHARMACOGENOMICS; PRIORITY JOURNAL; RACE DIFFERENCE; SHORT SURVEY; ARTICLE; ETHNIC GROUP; GENETICS; GENOMICS; HUMAN; LEGAL ASPECT; MEDICAL RESEARCH; PHARMACOGENETICS; RACE; UNITED STATES;

BIOMEDICAL RESEARCH; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; GENETIC VARIATION; GENOMICS; HUMANS; PHARMACOGENETICS; UNITED STATES;

EID: 58449133694     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1165768     Document Type: Short Survey

References (13)

1. Genomics and Personalized Medicine Act of 2006, 109th Cong., 2d Sess. [introduced in the Senate (IS)], S.3822.IS.
2. Genomics and Personalized Medicine Act of 2007, 110th Cong., 1st Sess., S.976.IS.
3. C. N. Rotimi, Nat. Genet. 36, S43 (2004).
4. C. W. Yancy, Curr. Hypertens. Rep. 10, 276 (2008).
5. FDA Approves BiDil Heart Failure Drug for Black Patients, www.fda.gov/bbs/topics/news/2005/new01190.html.
6. J. Kahn, Yale J. Health Policy Law Ethics 4, 1 (2004).
7. S. S. Lee, Am. J. Publ. Health 95, 2133 (2005).
8. C. D. M. Royal, G. M. Dunston, Nat. Genet. 36, S5 (2004).
9. S. S. Lee, Genome Biol. 9, 404 (2008).
10. Today's Topics in Health Disparities - Race and Genetics: The Future of Personalized Medicine (Kaiser Family Foundation, Menlo Park, CA, 20 August 2008); www.kaisernetwork.org/health-cast/hcast-index.cfm?display= detail&hc=2884.
11. Medicines in Development for Major Diseases Affecting African Americans (Pharmaceutical Research and Manufacturers Association of America, Washington, DC, September 2007).
12. Minority Health Improvement and Health Disparity Elimination Act of 2007, 110th Congr., 1st Sess., S.1576.IS.
13. S.S.-J.L. was supported by the Ethical, Legal, and Social Implications Research Program, National Human Genome Research Institute, NIH, grants K01 HL72465 and P50 HG003389.